Moreover, based on the overexpression of BATF and IRF4 in exhausted T cells (89, 98), knockdown of BATF or IRF4 could remarkably enhance the tumor-killing ability of CAR-T cells by reversing their exhaustion and prolonging their persistence (89, 90). The gene discussed is IRF4; the disease is neoplasm.